Expert Insights From WCLC 2025 on Beamion LUNG-1: Phase Ib Study of Zongertinib in Patients With Previously Treated HER2-Mutant NSCLC and Baseline Brain Metastases

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Expert Insights From WCLC 2025 on ARROS-1: Phase I/II Study of Zidesamtinib for Patients With Advanced ROS1+ NSCLC After Prior ROS1 TKI

Content Format:

Conference Coverage

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Expert Insights From WCLC 2025 on DeLLphi-303: 1L Maintenance Therapy With Tarlatamab + PD-L1 Inhibitor in Extensive-Stage SCLC

Content Format:

Conference Coverage

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Expert Insights From WCLC 2025 on FLAURA2: Final Overall Survival of First-line Osimertinib ± Platinum-Based Chemotherapy in EGFR-Mutated Advanced NSCLC

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Expert Insights From WCLC 2025 on IMforte: Safety Analysis of Lurbinectedin + Atezolizumab vs Atezolizumab as First-line Maintenance Therapy in ES-SCLC

Content Format:

Conference Coverage

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Novel Frontline Maintenance Therapy Approaches and Targeted Therapies in Lung Cancers: Key Data From the 2025 World Conference on Lung Cancer

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Expert Highlights From the 2025 World Conference on Lung Cancer

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Focus on Molecular Testing for MET Exon 14–Skipping Mutations in Advanced NSCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Focus on Molecular Testing for MET Exon 14–Skipping Mutations in Advanced NSCLC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--